Redwood City, Calif.
Description: Avinger is a commercial-stage medical device company. The company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system. Avinger manufactures and sells a suite of products in the United States and select European markets. Its products include Lightbox imaging console, Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The company’s lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. Its lumivascular platform directs treatment towards plaque. Avinger’s products include its Lightbox console and other catheters, including Ocelot, Ocelot PIXL and Ocelot MVRX.
Competition: Abbott Laboratories, BARD, Boston Scientific, Cook Medical, Covidien, Johnson & Johnson, Medtronic, Boston Scientific, Cardiovascular Systems, Covidien, Spectranetics, Volcano
Exchange and Ticker: AVGR: Nasdaq
Filing Range: 4.62 million shares @ $12.00 to $14.00
Offering Price: $13.00
Close Price as of 1/30/15: $13.50
Offering Size: $65 million
Shares Outstanding: 10.2 million
Underwriters: Canaccord Genuity, Cowen
Co-manager: Oppenheimer & Co Inc, BTIG LLC, Stephens Inc
Company Counsel: Wilson Sonsini Goodrich & Rosati
Manager Counsel: Jones Day
Auditor: Ernst & Young LLP
Market Capitalization on 01/30/15: $138.1 million
Close Price on 1/30/15: $13.50
- Lucas Venture Group
- Undisclosed firm
- 12/11/13 n/a
- 9/15/14 $34.8M
Source: Data provided by Thomson Reuters.